Works matching IS 20406207 AND DT 2017 AND VI 8 AND IP 7

The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2017, v. 8, n. 7, p. 209, doi. 10.1177/2040620717710171

By:

• Brayer, Jason;
• Baz, Rachid

Publication type:

Article